FY2027 EPS Estimates for INSP Decreased by Leerink Partnrs

Inspire Medical Systems, Inc. (NYSE:INSP) – Leerink Partnrs lowered their FY2027 earnings per share (EPS) estimates for Inspire Medical Systems in a research report issued on Monday, November 25th. Leerink Partnrs analyst M. Kratky now expects that the company will post earnings per share of $3.57 for the year, down from their prior forecast of $3.63. The consensus estimate for Inspire Medical Systems’ current full-year earnings is $1.33 per share. Leerink Partnrs also issued estimates for Inspire Medical Systems’ FY2028 earnings at $5.69 EPS.

A number of other equities analysts have also weighed in on the company. KeyCorp lowered their target price on Inspire Medical Systems from $278.00 to $236.00 and set an “overweight” rating on the stock in a research note on Wednesday, August 7th. Royal Bank of Canada reiterated an “outperform” rating and set a $260.00 target price on shares of Inspire Medical Systems in a research note on Tuesday, November 5th. Stifel Nicolaus reiterated a “hold” rating and set a $200.00 target price (up previously from $170.00) on shares of Inspire Medical Systems in a research note on Tuesday, November 5th. Robert W. Baird raised their price objective on Inspire Medical Systems from $240.00 to $252.00 and gave the stock an “outperform” rating in a research note on Tuesday, November 5th. Finally, Bank of America upgraded Inspire Medical Systems from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $220.00 to $255.00 in a research note on Wednesday, November 20th. Three analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus target price of $233.58.

Inspire Medical Systems Trading Down 5.2 %

Shares of NYSE INSP opened at $189.05 on Tuesday. The firm has a market cap of $5.67 billion, a P/E ratio of 176.68 and a beta of 1.36. Inspire Medical Systems has a 1-year low of $123.00 and a 1-year high of $257.40. The business’s 50 day moving average is $199.01 and its 200-day moving average is $175.73.

Inspire Medical Systems (NYSE:INSP) last announced its earnings results on Monday, November 4th. The company reported $0.60 earnings per share for the quarter, topping analysts’ consensus estimates of $0.06 by $0.54. The company had revenue of $203.20 million for the quarter, compared to analyst estimates of $197.59 million. Inspire Medical Systems had a return on equity of 5.30% and a net margin of 4.37%. The firm’s quarterly revenue was up 32.6% compared to the same quarter last year. During the same quarter last year, the company earned ($0.29) earnings per share.

Institutional Investors Weigh In On Inspire Medical Systems

A number of large investors have recently modified their holdings of the business. Van ECK Associates Corp boosted its holdings in shares of Inspire Medical Systems by 7.5% in the 2nd quarter. Van ECK Associates Corp now owns 1,029 shares of the company’s stock valued at $138,000 after purchasing an additional 72 shares in the last quarter. Amalgamated Bank boosted its holdings in shares of Inspire Medical Systems by 4.1% during the 2nd quarter. Amalgamated Bank now owns 2,005 shares of the company’s stock valued at $268,000 after acquiring an additional 79 shares in the last quarter. Signaturefd LLC boosted its holdings in shares of Inspire Medical Systems by 45.9% during the 3rd quarter. Signaturefd LLC now owns 270 shares of the company’s stock valued at $57,000 after acquiring an additional 85 shares in the last quarter. The Manufacturers Life Insurance Company boosted its holdings in shares of Inspire Medical Systems by 0.4% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 21,193 shares of the company’s stock valued at $2,836,000 after acquiring an additional 92 shares in the last quarter. Finally, Quarry LP boosted its holdings in shares of Inspire Medical Systems by 30.9% during the 3rd quarter. Quarry LP now owns 449 shares of the company’s stock valued at $95,000 after acquiring an additional 106 shares in the last quarter. Institutional investors and hedge funds own 94.91% of the company’s stock.

Insider Buying and Selling at Inspire Medical Systems

In other Inspire Medical Systems news, Director Shawn Mccormick sold 800 shares of the firm’s stock in a transaction on Monday, September 9th. The stock was sold at an average price of $220.00, for a total value of $176,000.00. Following the sale, the director now owns 23,140 shares of the company’s stock, valued at approximately $5,090,800. This trade represents a 3.34 % decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Company insiders own 4.10% of the company’s stock.

About Inspire Medical Systems

Inspire Medical Systems, Inc, a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA.